Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A randomized, double-blind, double dummy, parallel group, active controlled trial to evaluate the antiviral efficacy of 400 mg QD neVirapine Extended Release formulation in comparison to 200 mg BID neVirapinE with Truvada
Greenberg, Richard
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
5/1/08
→
10/27/10
Funding
Boehringer-Ingelheim:
$3,000.00
View all
View less